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1. Introduction
   In today’s fast food life, our immune system is under 
constant attack at all times from countless antigens, 
whether it is from the food we eat, the air we breathe, the 
water we drink or nutritional imbalance in the diet. Daily 
rhythms can have a profound effect on immune response 
through hormonal modifications. Immunological diseases 
are growing at epidemic proportions that require aggressive 
and innovative approaches to the development of new 
treatments. Some of the factors leading to a weakened 
immune system include stress, exposure to environmental 
toxins, sedentary lifestyle, inadequate sleep, alcohol and 
tobacco abuse, malabsorption, antibiotics, chemotherapy, 
birth control pills, cortisone, and other drug therapies. 
Plants are invaluable sources of new drugs. There is an 
ever-growing interest for investing different species of 
plants to identify their potential therapeutic applications. 
Scientific studies on plants used in ethno-medicine have 
led to the discovery of many valuable drugs. Many more 
plants are still to be explored and offer scope for further 
investigation[1]. 
  The mammalian immune system is composed of many 
cell types including B cells, T cells, NK cells, neutrophils, 
basophils, eosinophils, macrophages, mast cells, and 
mediators, such as cytokines, that interact with non-
immune cell types and each other in complex and dynamic 
networks to ensure protection against foreign pathogens. 
When tissue homoeostasis is disturbed, macrophages and 
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mast cells immediately release soluble mediators, such as 
proinflammatory cytokines like TNF, and interleukins[2]. 
  Cytokines are elaborated by different types of cells, may 
act in autocrine, paracrine or endocrine manner, stimulate 
or regulate the growth and functions of nearby cells through 
specific receptors, and are highly potent as they are 
effective in picomolar quantities. They are truly language 
of communication between cells of the immune system. 
Immunomodulators can regulate the cytokine production 
such as tumor necrosis factor, interleukins and interferons 
and these cytokines may, inturn activate T-cells or NK 
cells[3]. Immunosuppression is a common consequence of 
long term cyclophosphamide (CP) therapy in cancer patient. 
Immunosuppressants have already been employed in 
transplantation surgery. Reduction of immunosuppressive 
effects may thus become beneficial to patients undergoing 
CP-chemotherapy[4]. In this study, we, therefore, assessed 
the protective effects of Averrhoa carambola (A. carambola) 
against cyclophosphamide-induced immunosuppression.
  A. carambola L. (Oxalidaceae) is commonly known as 
‘Kamrakh’, Carambola apple, or ‘Star fruit’ [5]. The plant 
is a small, handsome evergreen tree about 9.0 m in height 
with close dropping branches. A. carambola is traditionally 
found to be useful for many ailments. The leaves are 
antipruritic, antipyretic, anthelmintic and are also useful 
in scabies, intermittent fevers and elimination of intestinal 
worms. The genus Averrhoa contains two species, bilimbi 
(Averrhoa bilimbi L.) and carambola (A. carambola L.). 
A. carambola is considered the more important of two 
species[6-8]. Star fruit and has been used extensively 
for treatment of some diseases like inflammation[9], 
hypotensive[10], hepatotoxicity[11] and antioxidant[12]. It is 
an ingredient of various herbal formulations, which are 
used to support the immune system. Naturally occurring 
flavanoids, phenols, benzoquinones dihydrobesic alcohol, 
carotenoids and lutein are the main constituents of the 
plant A. carambola. It also contains two alkyl phenols, 
namely, 2, 5-dimethoxy-3-undecylphenol and 5-methoxy-
3-undecylphenol, with two known benzoquinones, 5-O-
methylembelin and 2-dehydroxy-5-O-methylembelin from 
the wood of Averrhoa carambola[13] and 毱-carotene, 毬
-cryptoflavin ,mutatoxanthin, 毬-carotene, 毬-apo-8′-
carotenal, cryptoxanthin, cryptochrome and lutein were 
present in fruit of carambola[14]. Even though this plant has 
gained scientific importance, however, there is no scientific 
report available in the literature against the effect of these 
phytoconstituents enriched extract in immune modulation. 
Therefore, the present study was undertaken to assess 
the in vivo antioxidant and immunomodulatory activity of 
A. carambola leaves extract against cyclophosphamide-
induced immunosuppression. 
2. Materials and methods
2.1. Plant material collection and authentication
  The fresh leaves of A. carambola were collected from the 
field area of Bahraich, district U.P. India. For identification 
and taxonomic authentication, sample of plant material 
was given to National Botanical Research Institute (NBRI) 
Lucknow, India. The plant material was confirmed and 
authenticated by Dr. A. K. S. Rawat, Scientist and Head, 
Pharmacognosy and Ethnopharmacology Division, National 
Botanical Research Institute Lucknow, India with report no. 
CIF-RB-2-132.
2.2. Preparation of methanol extract of A. carambola (MEAc) 
  Shade-dried and coarsely powdered A. carambola leaves 
(100 g) were soaked in 500 mL of methanol [methanol/drug 
mass ratio 5:1] and kept at room temperature for 48 h with 
intermittent mixing. Methanol extract of plant obtained after 
48 h of soaking was filtered using Whatman Qualitative 
Grade-1 filter paper and the resultant filtrates were 
concentrated under reduced pressure and finally vacuum 
dried. It was stored at 4 曟 for further use. 
2.3. Quality control and chemo profiling of MEAc 
  Extract complied with WHO limits on safety and purity with 
respect to physico-chemical evaluations (loss on drying, ash 
values, extractive values) and preliminary phytochemical 
screening as per WHO recommended guidelines for 
standardizations[15]. The qualitative analysis of the MEAc was 
performed on HPTLC comprising of densitometer (CAMAG 
Model-3 TLC scanner) equipped with win CATS 4 software, 
semi automatic sampler (Linornat-5) and documentation 
was carried out by CAMAG PROSTER 3 at 366 nm (CAMAG, 
Berlin, Germany). 
2.4. Drugs
  Cyclophosphamide (Endoxan from Cadila Healthcare 
limited, India) 50 mg/kg b.w. was used. The doses used in 
the present study were selected based on previous studies[11-
17]. All drugs were dissolved in pyrogen-free isotonic saline. 
Suspension of the MEAc was prepared in carboxy methyl 
cellulose (CMC, 0.3%) using pyrogen-free isotonic saline.
2.5. Test animals
  Healthy Swiss albino mice (25-30 g) of either sex were 
selected for the study. The animals were fed on commercial 
diet (Hindustan lever pellets, Bangalore) and water ad 
libitum. Each animal was used once. The experiments were 
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performed between 10.00 and 16.00 h. The experimental 
protocol has been approved by the institutional ethical 
committee with approval no IU/Pharm/PhD./CPCSEA/12/06.
2.6. Antigenic materials
  For the present study, the antigenic material used was 
sheep RBCs (SRBC). Fresh blood was collected from sheep 
sacrificed in the local slaughter house. It was mixed with 
Alsever’s solution in 1:1 proportion and was stored at 4 曟 in 
refrigerator.
Composition of Alsever’s solution:
Contents % W/ V
Glucose 2.05
Sodium chloride 0.42
Sodium citrate 0.80
Citric acid 0.55
  During the experimentation, adequate amount of blood 
was taken from the above stock solution (i.e. SRBCs, stored 
in Alsever’s solution) and was allowed to stand at room 
temperature. It was washed three times with pyrogen 
free normal saline (0.9% w/v NaCl). The RBC count of this 
suspension was determined by hemocytometer using 
Neubauer Chamber. The known amount of RBCs (0.5伊109 
cells/mL/100 g) was injected intraperitoneally to the mice as 
an antigenic challenge.
2.7. Immunosuppressant
  In the present study cyclophosphamide (CP) 50 mg/kg ip 
was used as immunosuppressing agent.
2.8. Dosing schedule
  Animals were divided into six groups (I-VI). Each group 
comprised of a minimum of six animals. Group I (control) 
received normal saline for 7 consecutive days, group II (CP) 
animals were injected with a single dose of CP on 6 day of 
initiation of experiment, group III (Plant extract AC1) animals 
and group IV (Plant extract AC2) animals were administered 
with plant extract for 7 consecutive days. Group V animals 
(Plant extract AC1+ CP) and group VI animals (Plant extract 
AC2+CP), were given plant extract treatment for 7 days with 
a single injection of CP ip on 6th day. For humoral response 
animals of all groups will be challenged with 0.2 mL of 10% 
SRBC ip on 5th day. 
2.9. Immunization schedule
  The mice belonging to the above groups were antigenically 
challenged with SRBC (0.5伊109 cells/mL/100 g) on 5th day 
intraparitoneally.
2.10. Humoral immune response model
  Measurement of antibody titer by hemagglutination 
reaction was performed by using method of Bin-Hafeez et al 
with some modification. The mice were lightly anesthetized 
with anesthetic ether. A fine capillary was gently inserted 
into the lower angle of eye at 45曘 and the blood was 
obtained from retro-orbital plexus. The blood was collected 
into vial and centrifuged for separating serum. The serum of 
mice was used for determination of hemagglutination titer. 
Micro titration plate having 96 cups was used for carrying 
out titration. Each cup was filled with (25 依 1) 毺L of normal 
saline. (25 依 1) 毺L of serum obtained from mice blood was 
added to 1stcup and was mixed with (25 依 1) 毺L of normal 
saline present in microtitration plate. In this way serial two 
fold dilutions of serum were prepared. To each cup (25 依 1) 
毺L of 1% v/v SRBC was added. The plate was incubated at 
37 ℃ for 1 h. and then was observed for agglutination. The 
antibody titer was expressed in terms of maximum dilution, 
which gave positive hemagglutination reaction[18,19].
2.11. Cellular immune response model 
  Cell mediated immune response was assessed by footpad 
reaction test. On 7th day, after measuring volume of footpad 
of both legs, SRBC (0.025伊109 cells) were injected in right 
paw and 0.025 mL of saline was injected in left paw. On 
8th day after 24 h, the paw volume was measured again to 
check the increase or decrease in volume. The increase in 
paw volume was considered as an index of cell mediated 
immunity[20,21].  
2.12. Blood parameters
  The blood withdrawn from the above antigenically 
challenged mice were used to estimate the hematological 
parameters like hemoglobin (Hb), RBC and WBC by usual 
standardized laboratory method[19].   
2.13. Body weight and relative organ weight determination
  Animals of all groups were sacrificed 24 h after the last 
dose. Body weight gain and relative organ weight (organ 
weight/100 g of body weight) of kidney, liver, and spleen 
were determined for each animal[18]. 
2.14. Assessment of antioxidant parameters
  In all group animals, spleen were collected after the 
scarification and washed immediately with ice cold saline 
to remove blood. Spleen tissues of mice were homogenized 
(10%) in phosphate buffer (pH 7.4). The homogenate 
was centrifuged at 12 000 g for 20 min at 4 ℃ to obtain 
supernatant and it was used for the estimation of LPO and 
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reduced glutathione (GSH) [22,23]. The activity of catalase 
(CAT) and superoxide dismutase (SOD) was measured by the 
methods described by Aebi, Kakkar, and Rotruck[24-26]. 
2.14.1. Assay of TBARS
  Lipid peroxidation is a free radical mediated event. 
The primary products of such damage are a complex 
mixture of peroxides which then breakdown to produce 
carbonyl compounds. The malondialdehyde (MDA) is one 
such carbonyl compound, which forms a characteristic 
chromogenic adduct with two molecules of TBA. The 
colourimetric reaction of TBA with MDA, a secondary 
product of lipid peroxidation, has been widely accepted for 
measuring lipid peroxidation. The total protein which was 
present in the homogenate was estimated by following the 
method which was described by Lowry et al[27] The units of 
the TBARS activity which were determined were expressed 
in terms of nmoles MDA/mg protein.
2.14.2. Assay of glutathione
  This spectrophotometric procedure was based on the 
method of Ellman i.e. DTNB [5, 5’-dithiobis-(2-nitrobenzoic 
acid)] is reduced by –SH groups to form one mole of 
2-nitro-5- mercaptobenzoic acid per mole of –SH, as 
described by Sedlak and Lindsay. The units of the GSH 
activity which were determined were expressed in terms of 
nmoles 毺g/mg protein[28].  
2.14.3. Assay of SOD
  The assay of SOD was carried out, based on the ability of 
the enzyme to inhibit the auto-oxidation of pyrogallol, as 
described by Marklund and Marklund. The total protein 
which was present in the homogenate was estimated by 
following the method which was described by Lowry et al[27]. 
The units of the SOD activity which were determined were 
expressed in terms of milligram of the total protein[29]. 
2.14.4. Assay of catalase
  In the UV range, H2O2 shows a continuous increase in the 
absorption with decreasing wavelength. The decomposition 
of H2O2 can be followed directly by the decrease in the 
absorbance at 240 nm. The difference in absorbance (ΔA) 
per unit time is a measure of the catalase activity. The units 
of the CAT activity which were determined were expressed 
in terms of nmol H2O2/mg protein[30]. 
2.15. Determination of TNF-毩, and IL-6 level 
  The concentrations of TNF-毩 and IL-6 in the mice serum 
were determined specific quantitative sandwich ELISA kits 
according to the instruction of the manufacturer purchased 
from eBioscience and Cayman Chemical USA.
2.16. Statistical analysis
  Data were statistically analyzed using student’s t-test to 
determine significant differences in data of various groups; P 
values less than 0.05 were considered significant. The values 
are expressed as means 依 SEM.
3. Results
3.1. Standardization of extract
  The physico-chemical characters such as total alcohol 
soluble extractive, water soluble extractive, ash value, 
acid insoluble ash, water-soluble ash, loss on drying and 
foreign matter analysis was done and results are presented 
in Table 1. The preliminary phytochemical investigation of 
the methanol extract of A. carambola showed the presences 
of phytosterols, flavanoids, acidic compound, carbohydrates, 
glycosides and alkaloids, results are tabulated in Table 2. 
The extract was analyzed qualitatively by HPTLC. Finger 
printing studies on methanol extract showed presence of 
various phytoconstituents with different intensities, with 
their respective Rf values (Figure 1).  Sample was applied 
on TLC plate (10 伊 20 cm Silica gel 60F254, Merck) by semi 
automatic TLC sampler using 100 毺L syringe. The plate was 
developed in pre-saturated horizontal chamber with solvent 
system comprising of n-butanol: Acetic acid: water (2:4:6). 
The plates were visualized under UV at 366 nm 
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3 0.05 35.2 0.06 54.1 5.81 0.09 3.2 912.9 7.34 unknown*
4 0.11 1.1 0.14 112.3 12.07 0.17 0.9 2666.3 21.44 unknown*
5 0.25 3.8 0.27 5.3 1.64 0.28 2.4 185.3 1.49 unknown*
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10 0.77 0.1 0.78 17.2 1.85 0.79 9.0 151.8 1.22 unknown*
11 0.80 5.8 0.81 11.7 1.26 0.84 0.3 156.7 1.26 unknown*
12 0.86 0.8 0.87 10.6 1.14 0.89 0.8 83.8 0.67 unknown*
Figure 1. HPTLC Finger printing of methanol extract of A. carambola 
leaves.
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Table 1
Physicochemical parameters of A. carambola leaves.
Quantitative parameter Values obtained   (%) w/w
Alcohol soluble extractive 12.2
Water soluble extractive 16.6
Total ash   8.5
Acid insoluble ash   1.7
Water - soluble ash   4.0
Loss on drying 11.3
Swelling index   2.0
Foreign matter   1.2
Table 2
Preliminary phytochemical analysis of methanol extract of 
A. carambola leaves.
S.No. Constituents A. carambola leaves
1 Alkaloids +
2 Carbohydrate +
3 Glycoside +
4 Phenolic compound and tannins +
5 Flavonoides +
6 Proteins and amino acids -
7 Sterols +
8 Acidic compound +
9 Lipids/fats -
3.2. Hemagglutinating antibody (HA) titer
  The HA titer was used to assess humoral immune response. 
The CP treatment produced decrease in the HA titer value 
after 2 h incubation with SRBCs (Table 3). Administration 
of both the tested doses (800 and 1 200 mg/kg, respectively) 
produced a significant increase in HA titer as evident from 
hemagglutination after incubation of the serum with SRBCs. 
The increase was found highly significant. Thus, the plant 
extract showed protective effects on humoral immunity.
Table 3
Effect of A. carambola (AC) extract on humoral immune response.
Group Treatment Mean antibody titer a (in terms 
of rank of cups of titer plate)依
SEM
Group I Control (Normal saline)  9.25依0.30
Group II Normal saline + CP   3.17依0.16b
Group III AC 800 mg/kg 10.50依0.22c
Group IV AC 1 200 mg/kg 11.25依0.25e
Group V AC 800 mg/kg+CP   5.30依0.55d
Group VI AC 1 200 mg/kg+CP   7.60依0.20d
aValues are expressed as mean 依 SEM of 6 mice, bP<0.001 Statistical 
significance versus Group I, cP<0.01 Statistical significance versus 
Group I, dP<0.001 Statistical significance versus Group II, eP<0.05 
Statistical significance versus Group I.
3.4. Delayed type hypersensitivity (DTH) reactions
  The cell-mediated immune response of A.carambola leaves 
extract was assessed by DTH reaction, i.e. foot pad reaction, 
as shown in Figure 2, the test extract produced a significant, 
dose-related increase in DTH reactivity in mice. Increase in 
DTH reaction in mice in response to cell dependent antigen 
revealed the stimulatory effect of A. carambola extract on T 
cells. The change in percentage deduction in footpad volume 
was also found significant.  
Table 4
Effect of A. carambola extract on relative organ weight.
Group Treatment
Relative organ weighta (g) 依 SEM
Liver Kidney Spleen
Group I Control (Normal saline) 5.14依0.01 1.367依0.45 0.622依0.05
Group II Normal saline + CP  4.82依0.17b  1.115依0.26c  0.334依0.06b
Group III AC 800 mg/kg  5.04依0.74c  1.325依0.02e  0.500依0.10c
Group IV AC 1 200 mg/kg  5.12依0.05e  1.330依0.26c   0.611依0.08b
Group V AC 800 mg/kg + CP  4.89依0.11d  1.352依0.25f  0.451依0.09d 
Group VI AC 1 200 mg/kg + CP  4.90依0.07f  1.340依0.53d  0.511依0.10f
aValues are expressed as mean 依 SEM of 6 mice, bP<0.001 Statistical significance versus Group I, cP<0.01 Statistical significance versus Group 
I, dP<0.001 Statistical significance versus Group II, eP<0.05 Statistical significance versus Group I, fP<0.01 Statistical significance versus Group 
II.
Table 5
Effect of A. carambola extract on hematological parametersa.
Group Treatment RBC (伊106/mm3) WBC(伊103/mm3) Hb (g/dL)
I Control: Normal saline 9.26依0.33     6.26依0.28 13.76依0.48
II Normal saline + CP 9.22依0.21      1.52依0.17c  12.52依0.78b
III AC 800 mg/kg  9.53依0.14c     7.65依0.85  13.36依0.92c
IV AC 1 200 mg/kg 9.47依0.38      7.93依0.40b  13.65依0.51c
V AC 800 mg/kg + CP 9.24依0.21     3.21依0.53  12.33依0.28d
VI AC 1 200 mg/kg + CP 9.29依0.57      3.99依0.30d  12.39依0.31d
aValues are expressed as mean 依 SEM for 6 mice, bP<0.001 Statistical significance versus Group I, cP<0.01 Statistical significance versus Group 
I, dP<0.001 Statistical significance versus Group II, RBC (million/mm3), WBC (thousand/mm3), Hemoglobin (g/dL)
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Figure 2. Effect of A. carambola extract on Delayed Type 
Hypersensitivity Response. Values are expressed as mean 依 
SEM of 6 mice, bP<0.001 Statistical significance versus Group I, 
cP<0.01 Statistical significance versus Group I, dP<0.001 Statistical 
significance versus Group II, eP<0.05 Statistical significance versus 
Group II.
3.5. Effect on relative organ weight
  CP injection caused a prominent reduction in relative 
organ weight (kidney, liver, and spleen) of the mice (Table 4) 
recovery was also observed significant in each organ.
3.6. Effect on hematological parameters
  Cyclophosphamide at the dose of 50 mg/kg, i.p. caused a 
significant reduction in the hemoglobin, RBCs and WBCs 
(Table 5). Combined treatment of cyclophosphamide and
A. carambola extract, restoration of bone marrow activity as 
compared with cyclophosphamide alone treated mice was 
observed.
3.7. Effect of A. carambola leaves extract on LPO and levels 
of antioxidant enzymes 
  The oxidative stress marker studies revealed (Figure 3-6) 
that the administration of cyclophosphamide significantly 
increased the levels of LPO, decreased the activities of 
SOD, CAT and reduced the content of GSH as compared 
to the control group. The A. carambola leaves extract 
showed a moderate effect on LPO, SOD, CAT, and GSH. The 
cyclophosphamide treatment along with A. carambola leaves 
extract decreased TBA reactive products as compared to the 
cyclophosphamide-exposed group. Moreover, a significant 
elevation in the CAT and GSH content was also observed 
in comparison to cyclophosphamide-treated animals. SOD 
activity also increased when treated with A. carambola 
extract (MEAc) as compared to the cyclophosphamide control 
group.
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Figure 3.  Effect of MEAc on oxidative stress parameter (LPO), 
MEAC= methanol extract of A. carambola CP=cyclophosphamide, 
LPO=lipid peroxidation, aValues are expressed as mean 依 SEM of 
6 mice, bP<0.05 Statistical significance versus Group I, cP<0.01 
Statistical significance versus Group I, dP<0.001 Statistical 
significance versus Group I, eP<0.01 Statistical significance versus 
Group II, fP<0.001 Statistical significance versus Group II.
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Figure 4.  Effect of MEAc on oxidative stress parameter (GSH), 
MEAC = methanol extract of A. carambola CP=cyclophosphamide, 
GSH=reduced glutathione., aValues are expressed as mean 依 
SEM of 6 mice, bP<0.05 Statistical significance versus Group I, 
cP<0.01 Statistical significance versus Group I, dP<0.001 Statistical 
significance versus Group I, eP<0.01 Statistical significance versus 
Group II, fP<0.001 Statistical significance versus Group II.
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Figure 5. Effect of MEAc on oxidative stress parameter (SOD), 
MEAC = methanol extract of A. carambola CP=cyclophosphamide 
SOD=superoxide dismutase, aValues are expressed as mean 依 
SEM of 6 mice, bP<0.05 Statistical significance versus Group I, 
cP<0.01 Statistical significance versus Group I, dP<0.001 Statistical 
significance versus Group I, eP<0.01 Statistical significance versus 
Group II, fP<0.001 Statistical significance versus Group II.
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Figure 6. Effect of MEAc on oxidative stress parameter (CAT), Values 
are mean依SEM of 6 mice. MEAC = methanol extract of A. carambola 
CP=cyclophosphamide CAT=catalase. bP<0.05 Statistical significance versus 
Group I, cP<0.01 Statistical significance versus Group I, dP<0.001 Statistical 
significance versus Group I, eP<0.01 Statistical significance versus Group II, 
fP<0.001 Statistical significance versus Group II.
3.8. Effect of MEAc on proinflammatory cytokine
  Effect of test drugs on proinflammatory cytokine production 
showed that the extract treated animals showed significant 
up regulation of (IL-6 and TNF-毩) cytokines in a dose-
dependent manner in comparison to normal control animal. 
(Figure 7&8) While levels of TNF-毩 and IL-6 were 
decreased by the treatment with cyclophasphamide which 
was then significantly increased in comparison to model 
control animals, by the administration of A. carambola 
extract along with cyclophasphamide.
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Figure 7. Effect of A. carambola methanol extract (MEAc) on 
proinflammatory cytokine level (A) Tumor necrosis factor-毩 (TNF-
毩); (B) Interleukin-6 (IL-6), Concentration was expressed in pg/mL. 
Data were expressed as the mean 依 SEM of n = 6 animals per group. 
bP<0.05 Statistical significance versus Group I, cP<0.01 Statistical 
significance versus Group I, dP<0.01 Statistical significance versus 
Group II, eP<0.001 Statistical significance versus Group II.
4. Discussion
  Considering the structural data, we could state that
A. carambola posses the immunostimulatory principles. 
Immunomodulators are being used as an adjuvant in 
conditions of immunodeficiency in cancer and to a limited 
extent in acquired immunodeficiency syndrome. Many of the 
presently available immunomodulators such as levamisole, 
glucans, L-fucose as well as Corynebacterium parvum 
bacterium, are not free from side effects, which include 
fever, neutropenia, leucopenia and, at times, allergic 
reactions. Hence, screening for new immunomodulators is 
an urgent need. Immunomodulatory agents of plant origin 
enhance the immune responsiveness of the organism against 
a pathogen by activating the immune system. However, 
these agents should be subjected to systemic studies to 
substantiate the therapeutic claims made with regard to their 
clinical utility. 
  MEAc has ability to modulate humoral immune responses 
by acting at various levels in immune mechanism such as 
antibody production, release of mediators of hypersensitivity 
reactions, and tissue responses to these mediators in the 
target organs. In our study, foot volume was enhanced 
after A. carambola treatment, suggesting cell-mediated 
immune enhancement.  The high values of hemagglutinating 
antibody titer obtained in the A. carambola leaves extract 
indicated that immunostimulation was achieved through 
humoral immunity. Cell-mediated immunity (CMI) involves 
effector mechanisms carried out by T lymphocytes and their 
products (lymphokines). The CMI responses are critical to 
defend against infectious organisms, infection of foreign 
grafts, tumor immunity and delayed type hypersensitivity 
reactions. The results obtained shows that A. carambola 
(MEAc) given to the mice increases the number of antibodies 
in their serum while produces an inhibitory effect on cell-
mediated immune response. As the results the drug can be 
suggested for its therapeutic usefulness in various infections 
and inflammatory diseases. In case of chemotherapy of 
cancer patients, it can be a beneficial tool to reduce the 
humoral immunosuppressive effects. Humoral antibodies 
that are capable of killing free tumor cells in blood and 
in serosal cavities have been suggested to play a very 
important role in cancer. Cyclophosphamide (CP) is an 
alkylating agent commercially used in antineoplastic 
chemotherapy. Both experimental and clinical results have 
demonstrated an apparently paradoxical effect of CP on 
the tumor-host immune response. The better anti-tumor 
effect of CP depends on the larger dose of CP administered. 
However, along with a reduction of the tumor mass, large 
doses of CP usually bring an impairment of the host 
defense mechanisms, leading to immunosuppressive and 
cytotoxic effects[31-33]. To explore the possibility for adjuvant 
immunotherapy in severely immunosuppressed mice, the 
immunomodulatory activity of A. carambola (MEAc) was 
evaluated by the model of intensive chemotherapy with CP 
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in mice, and its effects on cellular and humoral immunity 
were investigated. In the present study, MEAc exhibited 
beneficial actions on the specific and nonspecific immunity 
of immunosuppressed mice at the optimal dose. The actions 
of CP are primarily directed toward the depletion of T/
B lymphocytes and the deficiency of macrophages[34]. A 
significant increase in white blood cell count was observed 
in methanol extract- treated mice as compared with 
cyclophosphamide treatment alone. Extract significantly 
ameliorated the RBC count, hemoglobin and also restored 
the suppressive effects induced by cyclophosphamide. 
  Toxicities of cyclophosphamide include the suppression 
of white blood cells, RBC, Hb, nausea, vomiting, gonadal 
atrophy, liver, renal, and bladder injury. Several visual 
symptoms, such as lethargy, alopecia, unusual weakness 
and anorexia. During chemotherapy, cylophosphamide also 
causes hepatic damage as well as urotoxicity, which is a 
problem associated with internal organs due to its cytotoxic 
nature[35,36].  Significant improvements were found in relative 
organ weights of kidney, liver, and spleen; therefore, MEAc 
could be suggested for the drug-induced immunopathy in 
the organs.
  While screening the immunomodulatory activity, most of 
the studies employ agents like cisplatin, cyclophosphamide 
or corticosteroids in order to induce the immunosuppression 
in the experimental animals[37]. These agents are known to 
generate free radicals in the biological system and thereby 
cause oxidative stress[38]. However, several workers have 
demonstrated that pro-oxidants suppress the immune 
responses in experimental animals[39]. In addition, it has 
been documented that the immunomodulators isolated 
from plant sources possess antioxidant activity[40]. The 
present study had shown that the administration of 
cyclophosphamide not only impair the immune responses 
but also produce oxidative stress in mice. In view of this, 
it appeared that cyclophosphamide which is a strong 
generator of superoxide radicals might impair the immune 
response through oxidative stress. It is further observed that 
administration of A. carambola leaves extract prevented the 
cyclophosphamide-induced changes of immunological and 
oxidative stress parameters. Hence, the immunomodulatory 
effect of A. carambola extract may be subsequent to the 
antioxidant activity which it possesses.
  The inflammatory response in the body is mediated by 
the proinflammatory cytokines such as tumor necrosis 
factor alpha (TNF-毩) and interleukin-6 (IL-6). The level 
and persistence of TNF-毩 and IL-6 cytokines play an 
important role in determining the behavior of a given 
factor in immunomodulation. IL-6 plays a key role in host 
immune responses, such as acute protein synthesis, and 
the maintenance of homeostasis also acts as both a pro-
inflammatory and anti-inflammatory cytokine[41]. Our result 
shows that test drugs induce cytokine production (including 
IL-6 and TNF-毩) in a dose-dependent manner. 
  Investigations characterizing the secondary metabolites of 
leaves of Averrhoa carambola have identified C-glycoside 
flavones, such as apigenin-6-C-毬-L-fucopyranoside 
and apigenin-6-C-(2”- O-毩-L-rhamnopyranosyl)-毬
-L-fucopyranosid. It is also known as carambolaflavone[15]. 
It might be possible that the immunostimulatory activity 
of leaves of Averrhoa carambola was due to the presence 
of these phytoconstituents. Because in previous reports 
flavanoids and terpenes mediate production of inflammatory 
cytokine[42] and shows its protective effect of on ethanol - 
induced immunosupression in rats[43]. 
  In conclusion this study shows that the methanol extract 
of leaves of A. carambola (MEAc) could possibly have 
both antioxidant and immunostimulatory capabilities. The 
reactive oxygen species and hyper immune activation are 
thought to be associated with the pathogenesis of chronic 
diseases such as inflammatory diseases and HIV/AIDS, and 
HIV infected individuals have impaired antioxidant defenses, 
the inhibitory effect of the A. carambola extract (MEAc) on 
free radicals and humoral immune response stimulation 
may partially explain why the A. carambola leaves extract 
is beneficial in ameliorating disease conditions. Protection 
of immune system by dietary antioxidants may play an 
important role in preserving the immune function and 
achieving healthy ageing. The accruing knowledge from this 
research is opening up new avenues for targeting cytokines 
and their receptors, or subunits shared by cytokines or their 
receptors, to treat undesirable inflammatory conditions. 
Further studies on the specific mechanism of action of
A. carambola extract and its semisynthetic derivatives, in 
order to establish its therapeutic potential for the prevention 
of immune diseases are required. 
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